Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background. In 1999, meningococcal serogroup C conjugate (MCC) vaccines were introduced in the United Kingdom for those under 19 years of age. The impact of this intervention on asymptomatic carriage of meningococci was investigated to establish whether serogroup replacement or protection by herd immunity occurred. Methods. Multicenter surveys of carriage were conducted during vaccine introduction and on 2 successive years, resulting in a total of 48,309 samples, from which 8599 meningococci were isolated and characterized by genotyping and phenotyping. Results. A reduction in serogroup C carriage (rate ratio, 0.19) was observed that lasted at least 2 years with no evidence of serogroup replacement. Vaccine efficacy against carriage was 75%, and vaccination had a disproportionate impact on the carriage of sequence type (ST)-11 complex serogroup C meningococci that (rate ratio, 0.06); these meningococci also exhibited high rates of capsule expression. Conclusions. The impact of vaccination with MCC vaccine on the prevalence of carriage of group C meningococci was consistent with herd immunity. The high impact on the carriage of ST-11 complex serogroup C could be attributed to high levels of capsule expression. High vaccine efficacy against disease in young children, who were not protected long-term by the schedule initially used, is attributed to the high vaccine efficacy against carriage in older age groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The reduction in carriage lasted for at least 2 years after vaccine introduction, with no evidence of serogroup replacement (199).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263
Multilocus Sequence Typing of Bacteria
Maiden, M. C. J. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121325 · Cited by 915
Self-citationEffectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · cited 1×
“This was fortuitous given that the infant schedule used for MCC vaccines in the United Kingdom at the time of vaccine introduction did not confer long term protection [27].”
BackgroundSelf-citationSequence type analysis and recombinational tests (START)
Jolley, K. A., Feil, E. J., Chan, M.-S., & Maiden, M. C. J. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1230 · Cited by 512
Self-citationmlstdbNet – distributed multi-locus sequence typing (MLST) databases
Jolley, K. A., Chan, M.-S., & Maiden, M. C. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-86 · Cited by 501
Self-citationMiller, E., Salisbury, D., & Ramsay, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 482
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421
Self-citationMaiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · cited 4×
“bacteria [13], which, although rarely isolated from carriers, are”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- 12. Jelfs J, Munro R, Ashton F, Rawlinson W, Caugant DA. Global study of variation in a new variant of the ET-37 complex of Neisseria meningitidis. In: Program and abstracts of the 11th International Pathogenic Neisseria Conference. Nice, France: Editions E.D.K., 1998 :5.
Cited by
Items 101–200 of 488
Li, Y., Gierahn, T. M., Thompson, C. M., Trzciński, K., Ford, C. B., Croucher, N. J., Gouveia, P., Flechtner, J. B., Malley, R., & Lipsitch, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002989 · Cited by 53
Novel approaches to Neisseria meningitidis vaccine design
Christodoulides, M., & Heckels, J. E. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx033 · Cited by 53
Borja-Tabora, C., Montalban, C., Memish, Z. A., der Wielen, M. V., Bianco, V., Boutriau, D., & Miller, J. M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-116 · Cited by 52
The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?
Maiden, M. C. J. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0147 · Cited by 52
Self-citationBurman, C., Serra, L., Nuttens, C., Presa, J. V., Balmer, P., & York, L. J. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1528831 · Cited by 52
Mbaeyi, S. A., Pondo, T., Blain, A. E., Yankey, D., Cubeñas-Potts, C., Cohn, A. C., Hariri, S., Shang, N., & MacNeil, J. R. (2020) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.1990 · Cited by 51
Herd Protection against Meningococcal Disease through Vaccination
Clark, S. A., & Borrow, R. (2020) · Microorganisms · doi:10.3390/microorganisms8111675 · Cited by 51
Gasparini, R., Comanducci, M., Amicizia, D., Ansaldi, F., Canepa, P., Orsi, A., Icardi, G., Rizzitelli, E., Angelis, G. D., Bambini, S., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03584-13 · Cited by 51
Hellenbrand, W., Elias, J., Wichmann, O., Dehnert, M., Frosch, M., & Vogel, U. F. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.008 · Cited by 50
Ishola, D., Borrow, R., Findlow, H., Findlow, J., Trotter, C. L., & Ramsay, M. E. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05655-11 · Cited by 50
Bai, X., Borrow, R., Bukovski, S., Caugant, D. A., Culic, D., Delic, S., Dinleyici, E. Ç., Eloshvili, M., Erdősi, T., Galajeva, J., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.10.018 · Cited by 50
Andrade, A. L., Minamisava, R., Tomich, L. G. M. D. M., de Lemos, A. P. S., Gorla, M. C., Brandileone, M. C. D. C., Domingues, C. M. S., de Moraes, C., Policena, G. M., Bierrenbach, A. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.010 · Cited by 49
van Ravenhorst, M. B., Bijlsma, M. W., van Houten, M. A., Struben, V. M. D., Anderson, A. S., Eiden, J., Li, H., Jansen, K. U., Jones, H. E., Kitchin, N. R. E., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.008 · Cited by 48
Hadad, R., Jacobsson, S., Pizza, M., Rappuoli, R., Fredlund, H., Olcén, P., & Unemo, M. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02903.x · Cited by 47
Ibarz-Pavón, A. B., MacLennan, J. M., Andrews, N., Gray, S. J., Urwin, R., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir466 · Cited by 46
Self-citationRise in Group W Meningococcal Carriage in University Students, United Kingdom
Oldfield, N. J., Cayrou, C., Aljannat, M., Al-Rubaiawi, A. A. A., Green, L. R., Dada, S., Steels, O. D., Stirrup, C., Wanford, J. J., Atwah, B. A. Y., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2306.161768 · Cited by 46
MacLennan, J. M., Rodrigues, C. M. C., Bratcher, H. B., Lekshmi, A., Finn, A. H. R., Oliver, J., Wootton, M., Ray, S., Cameron, C., Smith, A. J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30842-2 · Cited by 46
Self-citationMeningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia
Haidara, F. C., Umesi, A., Sow, S. O., Ochoge, M., Diallo, F., Imam, A., Traore, Y., Affleck, L., Doumbia, M. F., Daffeh, B., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2214924 · Cited by 46
Sampling methods to detect carriage of Neisseria meningitidis; literature review
Roberts, J., Greenwood, B. M., & Stuart, J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.12.005 · Cited by 46
Self-citationBiosynthesis and production of polysialic acids in bacteria
Ferrero, M. Á. M., & Rodríguez-Aparicio, L. B. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2531-5 · Cited by 46
Recent Progress in the Prevention of Serogroup B Meningococcal Disease
Feavers, I. M., & Maiden, M. C. J. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00566-16 · Cited by 45
Self-citationImpact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage
Delbos, V., Lemée, L., Bénichou, J., Berthelot, G., Deghmane, A., Leroy, J., Houivet, E., Hong, E., Taha, M., & Caron, F. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.080 · Cited by 44
Tartof, S. Y., Cohn, A. C., Tarbangdo, F., Djingarey, M. H., Messonnier, N. E., Clark, T. A., Kambou, J. L., Novak, R. T., Diomandé, F. V. K., Médah, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063605 · Cited by 44
The Evolution of the Meningitis Vaccine Project
Tiffay, K., Jódar, L., Kiény, M.-P., Socquet, M., & LaForce, F. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ594 · Cited by 43
Kaaijk, P., van der Ende, A., Berbers, G., van den Dobbelsteen, G. P., & Rots, N. Y. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-35 · Cited by 42
Stoof, S. P., Heijstek, M. W., Sijssens, K. M., van der Klis, F. R. M., Sanders, E. A. M., Teunis, P. F. M., Wulffraat, N. M., & Berbers, G. A. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202561 · Cited by 42
Hoiseth, S. K., Murphy, E., Andrew, L., Vogel, U. F., Frosch, M., Hellenbrand, W., Abad, R., Vázquez, J. A., Borrow, R., Findlow, J., et al. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31829aa63b · Cited by 42
O’Connor, D., Png, E., Khor, C. C., Snape, M. D., Hill, A. V. S., van der Klis, F. R. M., Hoggart, C. J., Levin, M., Hibberd, M. L., & Pollard, A. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.053 · Cited by 42
Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century
Kriz, P., Wieffer, H., Holl, K., Rosenlund, M., Budhia, S., & Vyse, A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.117 · Cited by 41
Carriage of Neisseria meningitidis in the Hajj and Umrah mass gatherings
Yezli, S., Wilder‐Smith, A., & Saeed, A. A. B. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.11.014 · Cited by 41
Tzeng, Y., & Stephens, D. S. (2021) · Microorganisms · doi:10.3390/microorganisms9030519 · Cited by 41
Hepkema, H., Pouwels, K. B., ENDE, A. V. D., Westra, T. A., & Postma, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065036 · Cited by 41
de Moraes, J. C., Kemp, B., de Lemos, A. P. S., Gorla, M. C., Marques, E. G. L., Ferreira, M. D. C., Sacchi, C. T., Carvalhanas, T. R. M. P., Ribeiro, A. F., Ferreira, C. M., et al. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000853 · Cited by 41
Biofilm formation by the human pathogen Neisseria meningitidis
Lappann, M., & Vogel, U. F. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0149-y · Cited by 40
Herd immunity: recent uses in vaccine assessment
Gonçalves, G. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.10.1493 · Cited by 40
Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies
Sáfadi, M. A. P., & McIntosh, E. D. G. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.159 · Cited by 39
Climent, Y., Yero, D., Martínez, I., Martin, A. M., Jolley, K. A., Sotolongo, F., Maiden, M. C. J., Urwin, R., & Pajón, R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01653-09 · Cited by 39
Self-citationAustralian Meningococcal Surveillance Programme annual report, 2013
Lahra, M. M., & Enriquez, R. P. (2014) · Communicable Diseases Intelligence · doi:10.33321/cdi.2014.38.50 · Cited by 38
Shirley, M., & Dhillon, S. (2015) · BioDrugs · doi:10.1007/s40259-015-0139-0 · Cited by 37
Vesikari, T., Forstén, A., Bianco, V., der Wielen, M. V., & Miller, J. M. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000897 · Cited by 37
Dull, P. M., & McIntosh, E. D. G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.062 · Cited by 36
Metabolisches Glykoengineering mit N‐Acyl‐Seiten‐ ketten‐modifizierten Mannosaminen
Wratil, P. R., Horstkorte, R., & Reutter, W. G. (2016) · Angewandte Chemie · doi:10.1002/ange.201601123 · Cited by 36
Lucidarme, J., Lekshmi, A., Parikh, S. R., Bray, J. E., Hill, D. M. C., Bratcher, H. B., Gray, S. J., Carr, A. D., Jolley, K. A., Findlow, J., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.015 · Cited by 36
Self-citationImpact of vaccination on meningococcal epidemiology
Stefanelli, P., & Rezza, G. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1108502 · Cited by 36
Shirley, M., & Taha, M. (2018) · Drugs · doi:10.1007/s40265-018-0869-7 · Cited by 36
Mass chemoprophylaxis for control of outbreaks of meningococcal disease
McNamara, L. A., MacNeil, J. R., Cohn, A. C., & Stephens, D. S. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30124-5 · Cited by 36
Vaccines for the Unvaccinated: Protecting the Herd
Stephens, D. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/527402 · Cited by 36
Borja-Tabora, C., Montalban, C., Memish, Z. A., Boutriau, D., Kolhe, D. A., Miller, J. M., & der Wielen, M. V. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1138-y · Cited by 35
Scott, J. R., Hinds, J., Gould, K. A., Millar, E. V., Reid, R., Santosham, M., O’Brien, K. L., & Hanage, W. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis307 · Cited by 35
Knuf, M., Romain, O., Kindler, K., Walther, U., Tran, P. M., Pankow-Culot, H., Fischbach, T. J., Kieninger‐Baum, D., Bianco, V., Baine, Y., et al. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-012-1924-0 · Cited by 35
Vesikari, T., Forstén, A., Boutriau, D., Bianco, V., der Wielen, M. V., & Miller, J. M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22165 · Cited by 35
Evolutionary and Genomic Insights into Meningococcal Biology
Bratcher, H. B., Bennett, J. S., & Maiden, M. C. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.62 · Cited by 35
Self-citationAustralian Meningococcal Surveillance Programme Annual Report, 2023
the National Neisseria Network, A., Lahra, M. M., George, C. R., van Hal, S. J., & Hogan, T. R. (2024) · Communicable Diseases Intelligence · doi:10.33321/cdi.2024.48.52 · Cited by 35
Meningococcal Carriage Among Georgia and Maryland High School Students
Harrison, L. H., Shutt, K. A., Arnold, K. E., Stern, E. J., Pondo, T., Kiehlbauch, J. A., Myers, R. A., Hollick, R. A., Schmink, S. E., Vello, M. S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu679 · Cited by 35
Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the US
Davis, K. L., Misurski, D. A., Miller, J. M., BELL, T. J., & Bapat, B. (2011) · Human Vaccines · doi:10.4161/hv.7.1.13692 · Cited by 34
Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience
Miller, J. M., Mesaros, N. E., der Wielen, M. V., & Baine, Y. (2011) · Advances in Preventive Medicine · doi:10.4061/2011/846756 · Cited by 34
Ishola, D., Andrews, N. J., Waight, P., Yung, C.-F., Southern, J., Bai, X., Findlow, H., Matheson, M., England, A., Hallis, B., et al. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000750 · Cited by 33
Self-citationVaccines for prevention of group B meningococcal disease: Not your father's vaccines
Harrison, L. H. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.101 · Cited by 33
Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers
Badahdah, A.-M. M., Alghabban, F., Falemban, W., Albishri, A., Banik, G. R., Alhawassi, T. M., Abuelizz, H. A., Bakarman, M. A., Khatami, A., Booy, R., et al. (2019) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed4040127 · Cited by 32
Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A. J., MacLennan, J. M., Maiden, M. C. J., Ramsay, M. E., Ladhani, S. N., Trotter, C. L., Borrow, R., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020988 · Cited by 31
Self-citationHellenbrand, W., Koch, J., Harder, T., Bogdan, C., Heininger, U., Tenenbaum, T., Terhardt, M., Vogel, U. F., Wichmann, O., & von Kries, R. (2015) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-015-2253-z · Cited by 31
Bettinger, J. A., Deeks, S. L., Halperin, S. A., Tsang, R. S. W., & Scheifele, D. W. (2013) · Cited by 31
Pezzotti, P., Miglietta, A., Neri, A., Fazio, C., Vacca, P., Voller, F., Rezza, G., & Stefanelli, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.002 · Cited by 30
Evolving meningococcal immunization strategies
Sáfadi, M. A. P., Bettinger, J. A., Maturana, G. M., Enwere, G., & Borrow, R. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.979799 · Cited by 30
Khatami, A., Snape, M. D., John, T. M., Westcar, S., Klinger, C. L., Rollinson, L., Boutriau, D., Mesaros, N. E., Wysocki, J., Gałaj, A., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f728fd · Cited by 30
Meningococcal disease: The advances and challenges of meningococcal disease prevention
Yogev, R., & Tan, T. Q. (2011) · Human Vaccines · doi:10.4161/hv.7.8.16270 · Cited by 30
Increase of meningococcal serogroup Y cases in Europe: A reason for concern?
Bröker, M., Jacobsson, S., DeTora, L. M., Pace, D., & Taha, M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.20098 · Cited by 30
Potential of Recombinant Opa Proteins as Vaccine Candidates against Hyperinvasive Meningococci
Callaghan, M. J., Lewis, S. C., Sadarangani, M., Bailey, S. E. S., Chan, H., Ferguson, D. J. P., Derrick, J. P., Feavers, I. M., Maiden, M. C. J., & Pollard, A. J. (2011) · Infection and Immunity · doi:10.1128/iai.01338-10 · Cited by 30
Self-citationNew frontiers in meningococcal vaccines
Anderson, A. S., Jansen, K. U., & Eiden, J. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.50 · Cited by 29
Effectiveness of Meningococcal C Conjugate Vaccine in Salvador, Brazil: A Case-Control Study
Cardoso, C. W., Ribeiro, G. S., dos Reis, M. G., Flannery, B. L., & Reis, J. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123734 · Cited by 29
Oldfield, N. J., Green, L. R., Parkhill, J., Bayliss, C. D., & Turner, D. P. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix596 · Cited by 29
Models of immune selection for multi-locus antigenic diversity of pathogens
Georgieva, M., Buckee, C. O., & Lipsitch, M. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0092-5 · Cited by 28
Khatami, A., Peters, A., Robinson, H., Williams, N., Thompson, A., Findlow, H., Pollard, A. J., & Snape, M. D. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05354-11 · Cited by 28
Neisseria meningitidisB vaccines: recent advances and possible immunization policies
Gasparini, R., Amicizia, D., Domnich, A., Lai, P. L., & Panatto, D. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.880341 · Cited by 28
Rodrigues, C. M. C., Lucidarme, J., Borrow, R., Smith, A. H., Cameron, J. C., Moxon, E. R., & Maiden, M. C. J. (2018) · Emerging infectious diseases · doi:10.3201/eid2404.171480 · Cited by 28
Self-citationVaccine development against Neisseria meningitidis
Vogel, U. F., & Claus, H. (2010) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00178.x · Cited by 28
The important lessons lurking in the history of meningococcal epidemiology
Borrow, R., & Findlow, J. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2329618 · Cited by 27
Australian Meningococcal Surveillance Programme annual report, 2015
Lahra, M. M., Enriquez, R. P., & National Neisseria Network (2016) · Communicable Diseases Intelligence · doi:10.33321/cdi.2016.40.57 · Cited by 27
Tunkel, A. R., van de Beek, D., & Scheld, W. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00084-9 · Cited by 27
Lee, H. J., Rakić, B., Gilbert, M., Wakarchuk, W. W., Withers, S. G., & Strynadka, N. C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006049 · Cited by 27
Tunkel, A. R., van de Beek, D., & Scheld, W. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00089-8 · Cited by 27
Neisseria meningitidis (Meningococcus)
Granoff, D. M., & Gilsdorf, J. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00184-6 · Cited by 27
Broeker, M., DeTora, L. M., Cooper, C., & Stoddard (2011) · Infection and Drug Resistance · doi:10.2147/idr.s12716 · Cited by 26
MenACWY-TT vaccine for active immunization against invasive meningococcal disease
Papaevangelou, V., & Spyridis, Ν. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.32 · Cited by 26
Lorton, F., Chalumeau, M., Assathiany, R., Martinot, A., Bucchia, M., Roué, J., Bourgoin, P., Chantreuil, J., Boussicault, G., Gaillot, T., et al. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12500 · Cited by 26
Sakou, I.-I., Tzanakaki, G., Tsolia, M. N., Sioumala, M., Barbouni, A., Kyprianou, M., Papaevangelou, V., Τσίτσικα, Ά., Blackwell, C., Kafetzis, D. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.047 · Cited by 26
Stoof, S. P., van der Klis, F. R. M., van Rooijen, D. M., Knol, M. J., Sanders, E. A. M., & Berbers, G. A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100651 · Cited by 25
van Ravenhorst, M. B., van der Klis, F. R. M., van Rooijen, D. M., Sanders, E. A. M., & Berbers, G. A. M. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.007 · Cited by 25
Serra, L., York, L. J., Balmer, P., & Webber, C. (2018) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2018.05.012 · Cited by 25
Climate Influences on Meningitis Incidence in Northwest Nigeria
Abdussalam, A. F., Monaghan, A. J., Dukić, V., Hayden, M. H., Hopson, T. M., Leckebusch, G. C., & Thornes, J. E. (2013) · Weather Climate and Society · doi:10.1175/wcas-d-13-00004.1 · Cited by 25
Zhang, Y., Banks, C. J., & Heaven, S. (2012) · Cited by 24
van Soest, T. M., Chekrouni, N., van Sorge, N. M., Bijlsma, M. W., Brouwer, M. C., & van de Beek, D. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100640 · Cited by 24
Caini, S., Beck, N. S., Yacouba, H., Maiga, I., Chaibou, I., Hinsa, I., Adakal, A., Issoufou, A., Kim, S. H., & Pezzoli, L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.015 · Cited by 24
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
de Whalley, P., Snape, M. D., Plested, E. L., Thompson, B. A. V., Nuthall, E., Omar, O., Borrow, R., & Pollard, A. J. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-303893 · Cited by 24
Rojas, E. A. P., Hoyos, J. M., Oldfield, N. J., Lee, P., Flint, M., Jones, C. H., Ala’Aldeen, D. A. A., Jansen, K. U., & Anderson, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132140 · Cited by 24
Self-citationvan Ravenhorst, M. B., Marinović, A. B., van der Klis, F. R. M., van Rooijen, D. M., van Maurik, M., Stoof, S. P., Sanders, E. A. M., & Berbers, G. A. M. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.049 · Cited by 24
Barasuol, B. M., Guizzo, J. A., Fegan, J. E., Martínez-Martínez, S., Ferri, E. F. R., Gutiérrez-Martín, C. B., Kreutz, L. C., Schryvers, A. B., & Frandoloso, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-10627-0 · Cited by 24
Granoff, D. M., Pelton, S. I., & Harrison, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00029-x · Cited by 24
Annual report of the Australian Meningococcal Surveillance Programme, 2011
Lahra, M. M., & Enriquez, R. P. (2012) · Communicable Diseases Intelligence · doi:10.33321/cdi.2012.36.19 · Cited by 24
Davis, K. L., BELL, T. J., Miller, J. M., Misurski, D. A., & Bapat, B. (2011) · Applied Health Economics and Health Policy · doi:10.2165/11587330-000000000-00000 · Cited by 24
Metadata
- Authors
- Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'Aldeen, D. A. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., MacLennan, J., Cameron, J. C., & Stuart, J. M.
- Affiliations
- John Radcliffe Hospital (GB)
- Health Protection Agency (GB)
- Health Protection Agency Centre for Infections, London
- University of Southampton (GB)
- Bangor University (GB)
- National Public Health Service for Wales, Unit 1, Parc Nantgarw, Cardiff
- Imperial College London (GB)
- University of Nottingham (GB)
- Division of Microbiology, School of Molecular Medical Sciences, Institute of Infection Immunity and Inflammation University of Nottingham
- South West Peninsula Health Protection Unit, Lescaze Offices, Dartington, Devon
- Derriford Hospital (GB)
- University of Manchester (GB)
- Manchester Royal Infirmary (GB)
- Health Protection Scotland (GB)
- Corresponding author
- Maiden, Martin C J
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 197
- Issue
- 5
- Pages
- 737-743
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC6767871
- OpenAlex
- W2171028861
- Cited by
- 442
- References
- 41
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 16 · 2022: 10 · 2021: 21 · 2020: 18 · 2019: 21 · 2018: 29 · 2017: 32 · 2016: 24 · 2015: 40 · 2014: 22 · 2013: 28 · 2012: 45
- FWCI
- 35.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Wellcome Trust
- Scottish Executive Health Department
- Meningitis Trust
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- meningococcal serogroup C, conjugate vaccines, asymptomatic carriage, herd immunity, serogroup replacement, capsule expression, vaccine efficacy, young children, United Kingdom
- MeSH terms
- Adolescent, Adult, Carrier State, Cross-Sectional Studies, United Kingdom, Humans, Meningococcal Infections, Neisseria meningitidis, Serotyping, Meningococcal Vaccines, Immunity, Herd, Mass Vaccination, Neisseria meningitidis, Serogroup C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.